Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Ascelia Pharma AB

Closing information (x1000 SEK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 3,965 Less Arrow 2,014 More Arrow 18,119
Earnings before taxes -133,155 More Arrow -129,523 More Arrow -99,747
EBITDA -145,961 More Arrow -136,918
Total assets 218,569 More Arrow 333,493 Less Arrow 255,374
Current assets 160,869 More Arrow 274,611 Less Arrow 196,324
Current liabilities 37,517 Less Arrow 25,106 Less Arrow 18,362
Equity capital 180,859 More Arrow 307,834 Less Arrow 236,056
- share capital 34,871 Less Arrow 34,576 Less Arrow 23,489
Employees (average) 22 Less Arrow 20 Less Arrow 11

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 82.7% More Arrow 92.3% More Arrow 92.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -59.1% More Arrow -38.2% More Arrow -32.0%
Current ratio 428.8% More Arrow 1093.8% Less Arrow 1069.2%
Return on equity (ROE) -73.6% More Arrow -42.1% Less Arrow -42.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 2 More Arrow 9 Less Arrow 4
Chg. No. of employees % 10% More Arrow 82% Less Arrow 57%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.